The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer

PURPOSE: To investigate the impact of targeted treatment on direct medical costs of patients with advanced non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Medical records of 108 stage IIIB/IV NSCLC patients treated in Seoul National University Hospital between 2003 and 2009, were reviewed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Res Treat
Egile Nagusiak: Lee, June-Koo, Kim, Dong-Wan, Keam, Bhumsuk, Kim, Tae Min, Lee, Se-Hoon, Kim, Young-Joo, Heo, Dae Seog
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Cancer Association 2015
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4398109/
https://ncbi.nlm.nih.gov/pubmed/25544584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.227
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak